Clinicohematological profile of hepatomegaly and or splenomegaly at tertiary care centre
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251629Keywords:
Hepatomegaly, Splenomegaly, Clinico-hematological profile, Chronic myeloid leukemia, Acute Leukemia, Hemolytic AnemiaAbstract
Background: Hepatomegaly and splenomegaly have varied causes, including infections, hematologic disorders, and malignancies. Timely diagnosis is essential for effective management. This study assessed the etiology, clinical presentation, and hematological profiles of patients with hepatomegaly and/or splenomegaly.
Methods: A total of 100 patients undergoing evaluation at a tertiary care hospital from January 2023 to June 2024 were included. Clinical history, examination, hematological tests, and imaging were conducted. Peripheral smear, bone marrow examination, and biochemical tests were performed as needed.
Results: The mean age was 33.66±21.45 years, with 53% females. Fatigue was the most common symptom (14%), and fever often accompanied other complaints. Splenomegaly was most frequent (52%), followed by hepatosplenomegaly (30%) and hepatomegaly (18%). Lymphadenopathy was noted in 12% of cases. Mean hematological values included Hb 7.47 gm%, TLC 27,114.28/cm2, PLT 1.41 lac/cm2, MCV 83.82 fl, MCH 29.45 pg, and MCHC 32.92 g%. CML was the most common peripheral smear finding (20%), followed by acute leukemia (8%), hemolytic anemia (5%), and sickle cell disease/thalassemia (4% each). Bone marrow exams also showed CML (20%) and erythroid hyperplasia (11%). Biochemical abnormalities appeared in 10% of patients. Final diagnoses most commonly included CML (19%) and erythroid hyperplasia (11%).
Conclusion: Hepatomegaly and splenomegaly present with diverse hematologic profiles. The high prevalence of CML highlights the need for early recognition and intervention, especially in younger and female patients.
Metrics
References
Kalra A, Yetiskul E, Wehrle CJ. Physiology, Liver. Updated 2023 May In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available at: https://www.ncbi.nlm.nih. Accessed on 12 December 2024
Mebius RE, Kraal G. Structure and function of spleen. Nat Rev Immunol. 2005;5(8):606-16. DOI: https://doi.org/10.1038/nri1669
Agarwal D, Mittal A. Hematology- a diagnostic tool in cases of splenomegaly. Int J Biomed Adv Res. 2016;7(9):413-7. DOI: https://doi.org/10.7439/ijbar.v7i9.3553
Krishna SR, Ramireddy K, Sri Lakshmi BNVB, Lakshmi Silpa KS. Clinicopathological Study of Hepatomegaly in Children Up to 12 yrs (including neonates). Int J Sci Res. 2015;4(3):1763-4.
Dayal RS, Mathur GP, Prasad R, Wahi PN. Hepatomegaly in infancy and childhood: a clinicopathological study of 98 cases. Indian Pediatr. 1966;3(4):129-38.
Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol. 2013;2:484903. DOI: https://doi.org/10.1155/2013/484903
Ahammad F, Ali MY, Rahman SH, Fattah SA, Alam MT, Nahar S, Hassan MU. Aetiology of pyrexia with hepatosplenomegaly: Study of 50 cases in MMCH (Bangladesh). Faridpur Med Coll J. 2010;5(1):7-10. DOI: https://doi.org/10.3329/fmcj.v5i1.6805
Leite LA, Domingues AL, Lopes EP, Ferreira RD, Pimenta Filho AD. Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis. Rev Bras Hematol Hemoter. 2013;35:332-6. DOI: https://doi.org/10.5581/1516-8484.20130098
Sharma A, Gupta R, Singh S. Observations on the prevalence of hepatomegaly in children and young adults. J Ped Res. 2019;24(3):123-30.
Ghosh CK, Islam F, Ahmed E, Ghosh DK, Haque A, Islam QT et al. Etiological and Clinical Patterns of Isolated Hepatomegaly at Rajshahi, Bangladesh. Euroasian J Hepato-Gastroenterol. 2012;2(1):1-4. DOI: https://doi.org/10.5005/jp-journals-10018-1021
Singh R, Patel A, Mehta K. Gender differences in the prevalence of hepatomegaly and splenomegaly: A study on the impact of autoimmune liver diseases and chronic viral hepatitis. Int J Hepatol Res. 2014;28(4):200-8.
Gupta A, Sharma P, Bansal R. Female predominance in non-alcoholic fatty liver disease and autoimmune hepatitis: A cohort study. J Hepatic Med. 2017;22(5):345-52.
Zhang X, Smith J, Lee K. Fatigue as a prevalent symptom among patients with liver and spleen enlargement: Correlation with severity and systemic involvement. J Hepatol Gastroenterol. 2020;45(3):123-34.
Parmar D, Likhar KS. Prevalence of splenomegaly in Sickle cell anemia patients in relation to Haemoglobin. F. IJRRMS. 2013;3(3):18–20.
Lee Y, Kim H, Park S, Lee J. Prevalence and clinical significance of splenomegaly in patients with various hematological disorders. Heliyon. 2021;7(5):5234.
Shah V, Patel S, Desai M. Hepatomegaly prevalence in patients with metabolic syndrome and non-alcoholic fatty liver disease in a tertiary care hospital. Heliyon. 2017;3(9):1945.
Patel S, Kumar R, Shah M. Prevalence and clinical impact of hepatosplenomegaly in systemic conditions. Heliyon. 2017;3(11):1976.
Patel R, Sharma S, Gupta A. Prevalence and clinical relevance of lymphadenopathy in systemic inflammatory and autoimmune conditions. Heliyon 2020;6(3):4198.
Kumar A, Singh R, Gupta N. Clinical characteristics of lymphadenopathy in patients with hepatosplenomegaly: A retrospective analysis. Heliyon. 2017;3(11):1987.
Wang X, Li Y, Zhang L. The prevalence of hepatomegaly in patients with heart failure: A clinical study. Heliyon. 2021;7(2):3756.
Sharma A, Gupta S, Verma N. Prevalence and clinical profile of Chronic Myeloid Leukemia among patients with splenomegaly in a tertiary care center. J Hematologic Disorders Therapy, 2018;6(2):123-30.
Gupta P, Verma S, Sharma A. Prevalence and clinical significance of lymphadenopathy in patients with hepatomegaly and splenomegaly. Heliyon. 2018;4(12):1567.
Gupta P, Kumar S, Verma, R. Analysis of hepatomegaly prevalence in a clinical population. J Clin Epidemiol. 2020;35(2):89-95.
Gupta P, Verma S, Sharma A. Hepatosplenomegaly in clinical practice: Prevalence and etiological profile. Heliyon. 2019;5(4):3145.
Downloads
Published
How to Cite
Issue
Section
